Literature DB >> 309298

Fenfluramine and brain serotonin.

B V Clineschmidt, A G Zacchei, J A Totaro, A B Pflueger, J C McGuffin, T I Wishousky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 309298     DOI： 10.1111/j.1749-6632.1978.tb31526.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  19 in total

1.  Brief report: trichotillomania in an autistic male.

Authors:  G Hamdan-Allen
Journal:  J Autism Dev Disord       Date:  1991-03

2.  Effects of fenfluramine on autistic individuals residing in a state developmental center.

Authors:  E Yarbrough; U Santat; I Perel; C Webster; R Lombardi
Journal:  J Autism Dev Disord       Date:  1987-09

3.  Effect of fenfluramine on autistic symptoms.

Authors:  J A Kohler; G Shortland; C J Rolles
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

Review 4.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 5.  Clinical effects of fenfluramine on children with autism: a review of the research.

Authors:  G du Verglas; S R Banks; K E Guyer
Journal:  J Autism Dev Disord       Date:  1988-06

6.  Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man.

Authors:  H D Mühlbauer; B Müller-Oerlinghausen
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

Authors:  M E Benwell; P E Holtom; R J Moran; D J Balfour
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.

Authors:  J F McElroy; R S Feldman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

10.  Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?

Authors:  R Invernizzi; K Kmieciak-Kolada; R Samanin
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.